Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.
Hepatology. 2004 Dec;40(6):1450-8. doi: 10.1002/hep.20482.
Hepatology. 2004.
PMID: 15565613
Clinical Trial.
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.
Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ; Proactive Study Group.
Afdhal NH, et al. Among authors: goon bl.
Gastroenterology. 2004 May;126(5):1302-11. doi: 10.1053/j.gastro.2004.01.027.
Gastroenterology. 2004.
PMID: 15131791
Clinical Trial.
Item in Clipboard
Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin.
Balan V, Schwartz D, Wu GY, Muir AJ, Ghalib R, Jackson J, Keeffe EB, Rossaro L, Burnett A, Goon BL, Bowers PJ, Leitz GJ; HCV Natural History Study Group.
Balan V, et al. Among authors: goon bl.
Am J Gastroenterol. 2005 Feb;100(2):299-307. doi: 10.1111/j.1572-0241.2005.40757.x.
Am J Gastroenterol. 2005.
PMID: 15667486
Item in Clipboard
Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients.
Grossman HA, Goon B, Bowers P, Leitz G; 010 Study Group.
Grossman HA, et al.
J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):368-78. doi: 10.1097/00126334-200312010-00003.
J Acquir Immune Defic Syndr. 2003.
PMID: 14615654
Clinical Trial.
Item in Clipboard
Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects.
Cheung WK, Goon BL, Guilfoyle MC, Wacholtz MC.
Cheung WK, et al. Among authors: goon bl.
Clin Pharmacol Ther. 1998 Oct;64(4):412-23. doi: 10.1016/S0009-9236(98)90072-8.
Clin Pharmacol Ther. 1998.
PMID: 9797798
Clinical Trial.
Item in Clipboard
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
Sternberg CN, Castellano D, Daugaard G, Géczi L, Hotte SJ, Mainwaring PN, Saad F, Souza C, Tay MH, Garrido JM, Galli L, Londhe A, De Porre P, Goon B, Lee E, McGowan T, Naini V, Todd MB, Molina A, George DJ; Abiraterone Global EAP Investigators.
Sternberg CN, et al.
Lancet Oncol. 2014 Oct;15(11):1263-8. doi: 10.1016/S1470-2045(14)70417-6. Epub 2014 Sep 18.
Lancet Oncol. 2014.
PMID: 25242048
Clinical Trial.
Item in Clipboard
Cite
Cite